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ABSTRACT 
Objective: The genetic etiology for the majority of sutural growth disturbances, 
in humans, is unknown. Therefore, the development of our knowledge of the genes 
involved in suture fusion is essential for progress in the treatment of individuals with 
cranial suture fusion disorders. In this study, we have examined Distal-Iess-5 (Dlx5), a 
homeobox gene, which is required for Bone Morphogenic Protein (BMP)-mediated 
osteoblast differentiation and is thought to play an important role in the development of 
mineralized tissues. The significance ofDlx5 in these biologic processes has developed 
interest in the role of this gene in cranial suture fusion. Methods: We examined the 
expression of Dlx5 in the fusing and non-fusing cranial sutures of wild-type (wt) mice 
by RT-PCR and immunohistochemistry. In order to determine the role ofDlx5 in the 
cranial sutures, the Sagittal (S) and posterior frontal suture (PFS) were analyzed from 
Dlx5 +/- and wild-type mice at postnatal day 10. To determine ifDlx5 +/- mice had a 
decrease in osteoblast differentiation in the cranial sutures, Dlx5 +/- and wt mice were 
bred with mice transgenic for the 2.3 kb fragment of the collagen Type I promoter fused 
to a Green Fluorescent Protein (2.3 OFP). The 2.3 GFP promoter has been shown to be 
an accurate marker of differentiated osteoblastic cells (Kalajzic et al., 2002). Results: 
Dlx5 was abundantly expressed in the Sand PFS during sutural maturation (postnatal 
day (10-45) and there was an increase in the expression ofDlx5 in the posterior frontal 
suture (PFS) compared to the sagittal suture (S) at day 35. At day 10, there was an 
increase in space (p< 0.05) between the parietal bone fronts in the sagittal suture from 
Dlx5 compared to wt mice. Conclusiou: Genes involved, or thought to be involved, 
in cranial suture fusion are of great interest among those studying both normal and 
IV 
abnormal calvarial development. Knowledge of the intricate processes and genes 
responsible for proper growth of the cranium is essential to fmding therapies for 
patients who are affected by disorders involving abnormal sutural fusion, namely 
craniosynostosis. Evidence that a Dlx5 signaling pathway is involved in suture fusion, 




Cranial sutures function as the major sites of bone expansion during postnatal 
craniofacial growth and allow development of the skull to accommodate rapid growth 
ofthe brain. For sutures to function as growth sites, they need to remain unossified, and 
simultaneously allow formation of new bone at the edges of the overlapping bone 
fronts. Too little or delayed bone growth at these sutures results in wide-open fontanels, 
whereas too much or accelerated bone growth results in osseous obliteration of the 
sutures (Opperman 2000). 
Despite the obvious differences in human and murine craniofacial 
characteristics, there is a marked similarity and conservation in the molecular pathways 
for the assembly and growth ofthe cranial vault between the two species (Warren, 
Greenwald et aL 2001). In mice, all the sutures of the cranial vault remain patent for the 
life of the animal; except for the posterior frontal suture (PFS), which fuses in a 
predictable manner between 21-45 days postnatal (Opperman 2000). In humans, the 
equivalent metopic suture fuses within the first three years postnatal (Vu, Panchal et al. 
2001; Weinzweig, Kirschner et aL 2003). Therefore, the murine PFS serves as an 
excellent model of post-natal human sutural development (Warren, Greenwald et al. 
2001). 
BMP signaling has been linked to murine PFS fusion, and is expressed in 
developing (Kim, Rice et al. 1998) and in adult murine cranial sutures (Warren, Brunet 
et al. 2003). In fact, Warren et al. showed that inhibition ofthe BMP signaling 
pathway, by adenovirus mis-expression ofthe BMP antagonist Noggin, blocks murine 
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PFS fusion in vivo (Warren, Brunet et al. 2003). However, BMP added to murine 
calvarial organ culture sutures did not cause sutural fusion (Kim, Rice et al. 1998). 
Taken together, these results suggest that BMP is necessary but not sufficient for 
murine calvarial suture fusion. 
Many extracellular and intracellular proteins, such as Dlx5, regulate the BMP 
signaling pathway. In an avian calvarial explant culture system, Dlx5 transcription was 
upregulated by BMP and inhibited by the BMP antagonist Noggin (Holleville, Quilhac 
et al. 2003) which proved that Dlx5 acts downstream from BMP signaling. In 
subsequent investigations of osteoblastic cell cultures, it was shown that BMP causes an 
increase in the expression of Dlx5 (Miyama, Yamada et al. 1999; Takagi, Kamiya et al. 
2004), and that regulation of osteoblast differentiation by BMP is dependent on Dlx5. 
Others showed, that in osteoblast-like cells, BMP can induce markers of osteoblast 
differentiation including alkaline phosphatase (Kim, Lee et al. 2004), Runx2 (Lee, Kim 
et al. 2003), and Osterix (Lee, Kwon et al. 2003) all of which have been shown to be 
dependent upon Dlx5. 
RATIONALE 
The incidence of craniosynostosis in the United States is about .04-.1 %. 
Although this developmental disorder is rare, it may result in severe malformations of 
the cranial vault and in the more harshly affected, increased pressure on the brain. The 
most detrimental consequences described are mental impairment, loss of hearing, and 
poor vision. The severity of these complications requires that infants, sometimes at a 
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young age, receive several surgeries to avoid further damage and to correct the 
deformity. 
The genetic etiology for the majority of sutural growth disturbances in humans 
is unknown. Providing evidence that a Dlx5 signaling pathway is involved in sutural 
fusion, may make available a new candidate gene for analysis in patients with sutural 
growth disturbances. 
HYPOTHESIS 
In this study, we plan to examine the role of the transcription factor, Dlx5, in 
controlling murine cranial suture development and growth. We hypothesize that Dlx5 
expression will be increased in the murine PFS during the time of posterior frontal 
suture fusion and that there will be a decrease in suture fusion in the PFS in 
heterozygous Dlx5 (+1-) mice. 
SPECIFIC AIMS/OBJECTIVES/PREDICTIONS 
Aim 1. Examine the expression and localization of Db5 in the posterior 
frontal and the sagittal cranial sutures. 
The posterior frontal suture in mice fuses between days 21 and 45 postnatally. 
Our working hypothesis is that Dlx5 expression will increase in the PFS during the 
period of expected suture fusion (days 21-45 postnatal) relative to that in the non-fusing 
sagittal suture. We plan on testing this hypothesis by examining expression levels of 
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DlxS by RT-PCR and its localization by immunohistochemistry in the posterior frontal 
and sagittal sutures from CD-lmice postnatal day 21, 2S, 3S, and 4S. 
Aim 2. Examine the posterior frontal and sagittal sutures of 10 day-old 
wild-type and heterozygous Dlx5 (+1-) mice. 
Previous studies have shown that mice deficient in both alleles (DlxS -/-), die in 
utero, therefore we plan on examining heterozygous DlxS mice. In order for PF 
sutural fusion to occur, the bone fronts ofthe frontal bone must come in contact with 
each other, which occurs prior to PFS sutural fusion (postnatal day 21-4S). Therefore, 
our objective is to determine the extent of bone front spacing in the posterior frontal and 
sagittal sutures of 10 day-old wild-type and heterozygous DlxS (+/-) mice. Our working 
hypothesis is that there will be an increase in the space between bone fronts in the PFS 
in heterozygous DlxS (+/-) mice. 
BACKGROUND 
A. Cranial Sutures 
The skull vault is composed of paired frontal, parietal, squamosal portions of the 
temporal bones, and the anterior portion of the occipital bone. (Couly et al., 1993; Jiang 
et al., 2002; Noden, 1978, 1988). These bones form the calvaria and develop through 
intramembranous ossification; whereas, the bones that form the base of the skull 
develop through endochondral ossification (Morriss-Kay and Wilkie 200S). 
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In vertebrates, the skull develops from either neural crest, or mesodermal 
tissues. Chai et al. and Jiang et al., incorporated markers in mice that enabled 
visualization of the migration of cranial neural crest cells during development (Chai et 
aI., 2000 and Jiang et al. 2000, 2002). These studies showed that neural crest cells 
emigrate as three separate populations: the trigeminal crest, the hyoid crest, and the 
vagal crest. The trigeminal crest migrates to the frontonasal and first branchial arch 
regions and provides the neural crest component of the trigeminal ganglion; this is the 
only popUlation of neural crest cells that contributes to the skull. 
Cranial sutures separate the bones of the calvariae and form as the bony edges 
meet. Growth at these sutures occurs perpendicular to the orientation of the suture; 
normally, it coincides with the expansion ofthe brain (Morriss-Kay and Wilkie 2005). 
At birth, the cranial sutures are patent and the flexibility that results allows the bones of 
the cranium to overlap as the baby passes through the birth canal. Another significant 
task of the cranial sutures is their role as the primary sites of bone growth during 
craniofacial development. This is most notable during the period when the brain is 
rapidly expanding (Baer, 1954). 
The human metopic suture undergoes fusion during the first three years and all 
of the other cranial sutures remain patent well into adulthood (Weinzweig et al., 2003). 
In the mouse, the PFS, equivalent to the metopic or interfrontal suture in humans, fuses 
in the first 45 days oflife. However, all of the other sutures, including the sagittal and 
coronal, remain patent (Warren et at. 2001). Similarities between mice and humans in 
craniofacial development, the specific molecules involved, as well as the structure of 
those molecules make the murine posterior frontal suture an excellent model for the 
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study of human suture development and pathology (Richtsmeier et ai., 2000; Schneider 
et al., 1999; Waterston et al., 2002; Wilkie and Morriss-Kay, 2001). 
B.Dura 
The presence of the dura mater has been found to be essential for normal 
development and maintenance of cranial vault sutures (Opperman et aI., 2005). In fact, 
the ability of neonatal dura mater to regenerate bone has been observed clinically and 
demonstrated in several animal models (Lenton et ai., 2005). For example, it has been 
shown that the presence of intact dura is required for regeneration of the skull vault 
after removal of a small area of the calvaria in infants and young animals (Babler et at., 
1982; Mabbutt and Kokich, 1979; Mabbutt et al., 1979; Mossaz and Kokich, 1981). 
These findings and the intimate association between the dura mater and crania] sutures, 
initiated investigations by others, to determine a role for dura mater in suture 
development and fate (Lenton et al. ,2005). 
Opperman et al. transplanted embryonic and postnatal corona] sutures with and 
without dura mater to the midparietal bones of syngeneic adult rats and showed that 
both embryonic and postnatal suture explants fused in the absence of their original, 
suture-associated dura mater. On the other hand, explants of both sutures transplanted 
with their dura mater intact remained patent (Opperman et aI., 1993). Similar results 
were obtained when the embryonic sutures were placed in an in vitro organ culture 
system, with intact sutures remaining patent and those lacking their dura mater fusing 
(Opperman et at., 1995). These results suggested that factors and/or physical signals 
from the dura mater associated with the coronal suture are responsible in some way for 
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maintaining suture patency in the late embryonic and early postnatal stages of 
development. 
In subsequent studies, Opperman and colleagues added conditioned media from 
dura mater cultures to coronal suture explants placed in organ culture without their 
suture-associated dura mater. They showed that this conditioned media was capable of 
preventing suture fusion. When the media was divided into heparin and non-heparin 
binding fractions, only the heparin-binding was capable of maintaining coronal suture 
patency (Opperman et ai., 1996). These results suggested that heparin-binding growth 
factors, such as FGFs and Transforming Growth Factor-fJ (TGF-fJ) superfamily 
members, were responsible for differences in coronal suture fate (Opperman, et al., 
1996). 
The role of the dura mater in maintenance of suture patency has also been 
demonstrated in the sagittal suture (Kim et al., 1998). Embryonic (EI6) murine sagittal 
suture explants that were cultured without their dura mater, fused within three days; this 
contrasted with control explants, cultured with their dura intact, that remained patent. 
However, no difference was demonstrated in the patency of sagittal suture explants 
from postnatal (PI) mice cultured with and without their associated dura mater (Kim et 
al., 1998). This prompted investigators such as Kim et al. to study the expression of 
genes known to act in conserved signaling pathways throughout development. Different 
patterns of expression of these genes were found at the end of embryonic development 
in the osteogenic fronts of the sagittal suture. This suggested that different molecular 
mechanisms are responsible for suture morphogenesis during the embryonic and 
postnatal stages of development and lead to the hypothesis that in the murine sagittal 
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suture, the dura mater is responsible for maintaining suture patency prior to birth, while 
molecular signals from the osteogenic bone fronts are the principal regulators of suture 
patency during the neonatal stages of development (Kim et al., 1998). 
Other studies have focused on the effects of removal or disruption of the dura on 
PFS fusion. Separating the dura mater from the overlying PFS either temporarily or by 
placement of an impermeable silicone membrane, resulted in a significant delay in 
fusion of the PFS and suggested that there are interactions between the PFS and the 
dura during the process ofPFS fusion (Roth et al., 1996). 
Verification that molecules originating in the dura mater were responsible for 
coronal and sagittal suture patency, as well as PFS fusion, led to the hypothesis that the 
dura mater has a specific "make -up", based upon it's location, and is therefore capable 
of coordinating the differing fate of each cranial suture (Lenton et al., 2005). Levine et 
al. (1998) tested this hypothesis by removing a portion of the calvariae, in rats, 
containing both the posterior frontal and sagittal sutures without the dura mater and 
rotated it 1800 • This placed the dura that was previously associated with the PFS in 
contact with the sagittal suture and vice versa. The new position resulted in obliteration 
of the sagittal suture which normally remains patent and sustained patency of the 
normally fused PFS in vivo. 
The results of these experiments clearly indicate a role of the dura mater in 
determining cranial suture fate. 
C. Disturbances in Suture Fusion 
For sutures to function as growth sites, they need to remain patent, and allow new 
8 
bone to be formed at the edges of the overlapping bone fronts. Too much or accelerated 
bone growth results in osseous obliteration of the sutures; whereas too little or delayed 
bone growth results in wide-open fontanels (Opperman 2000). 
1. Craniosynostosis, or premature fusion of the cranial sutures, results in an 
abnormal skull shape, and may cause severe deformities such as blindness and mental 
retardation (McCarthy et at., 1989). Although the majority of craniosynostoses are 
nonsyndromic, more than 100 different syndromes have been identified that include 
craniosynostosis as one of their many characteristics (Wilkie, 1997). Because 
craniosynostosis is such a common finding among syndromes and may result in severe 
deformities, it is important to study the mechanisms and roles of the molecules involved 
in cranial suture fusion in an effort to develop therapies to treat the disorder. 
In the last ten years, some of the more common syndromes of these have been 
linked to dominant mutations in genes encoding Fibroblast Growth Factor Receptors 
(FGFR1, FGFR2, and FGFR3), and the transcription factors TWIST and Msx-2 (Bellus 
et at., 1996; EI Ghouzzi et at., 1997; Howard et at., 1997; Jabs et at., 1994, 1993; 
Oldridge et at., 1995; Reardon and Winter, 1994). Mutations ofFGFRs and Msx-2 
genes are usually described as gain-of-function mutations whereas TWIST mutations 
are known as loss-of-function mutations. (Opperman et at.,2000). Mutations in these 
genes and transcription factors account for about 25% of all cases of craniosynostosis 
(Twigg et at., 2004). 
Msx-2 (muscle segment homeobox 2) is a highly conserved homeobox gene that 
is involved in the regulation of inductive tissue interactions during embryogenesis (Jabs 
et at., 1993). A mutation ofthe Msx-2 gene was the first to be identified among gene 
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mutations associated with craniosynostosis (Jabs et al., 1993). Boston-type 
craniosynostosis is the only syndrome with craniosynostosis that is associated with 
mutations in the gene for Msx-2 (Jabs et al., 1993). The specific mutation associated 
with Boston-type craniosynostosis is a cysteine to adenosine transversion on the gene 
for Msx-2 that leads to an amino acid substitution. (Jabs et al., 1993), this results in an 
increase in DNA-binding ofthe Msx-2 protein and augmentation of the normal function 
ofMsx-2 (Ma et al., 1996). 
TWIST is a transcription factor that was originally identified as a principal 
stimulator of mesoderm formation in Drosophila (Lenton et al., 2005). Mutations in the 
gene encoding TWIST are also associated with craniosynostosis among many other 
abnormalities. Heterozygous TWIST-l mutations have been identified in 80% of 
patients with Saethre-Chotzen syndrome (Chun et al., 2002; Johnson et al., 1998). 
Some of the many abnormalities found in patients diagnosed with this disorder are, 
craniosynostosis involving one or both coronal sutures, midface hypoplasia, and facial 
asymmetry (El Ghouzzi et al., 1997; Johnson et al., 1998; Reardon and Winter, 1994). 
In contrast to the Msx-2 gain-of-function or overexpression mutation, the majority of 
TWIST -1 mutations resulting in craniosynostosis, produce haploinsufficiency and result 
in a lack of functional protein production (Paznekas et al., 1998; El Ghouzzi et al., 
1997). 
Heterozygous FGFR mutations are the most common genetic abnormality 
associated with syndromes including craniosynostosis in their phenotype (Lenton et al., 
2005). The most frequently occurring mutations are missense, or small in-frame 
insertions or deletions that affect the ligand-binding domain (Wilkie, 1997). Other 
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mutations involve the tyrosine kinase domain of the isofonn FGFR2 and are thought to 
have an impact on downstream signaling pathways (Kan et a/., 2002). However, most 
mutations of this gene are dominant and are believed to result in a gain of function by 
either increasing ligand binding affinity, decreasing the specificity of receptor-ligand 
interactions, or increased receptor dimerization and stabilization (Lenton et a/., 2005). 
Most of the FGFR mutations that cause craniosynostotic syndromes are 
mutations of the FGFR2 isoform. In fact, two mutations that result in an increase in 
function account for almost all of the cases of Apert syndrome (Lenton et a/., 2005). In 
addition, other mutations of the FGFR2 gene have been associated with Pfeiffer and 
Crouzon syndromes. An analogous mutation, to one found in the gene encoding FGFR2 
that causes Apert syndrome, has been identified in the FGFRI gene, and is responsible 
for some cases of Pfeiffer syndrome (Robin et a/., 1994; Wilkie et a/., 1995). Two 
mutations in the FGFR3 gene have been linked to Muenke syndrome and type I 
thanatophoric dysplasia (Bellus et aI., 1996; Muenke et a/., 1997, 1994; Tavonnina et 
a/., 1995). 
2. Enlarged Parietal Foramina 
Too little sutural growth results in a disease known as Enlarged Parietal 
Foramina. Loss-of-function mutations in the transcription factors Alx-4 and Msx-2 have 
been associated with this disorder among many others in development. 
Alx-4 and Msx-2 encode homeodomain transcription factors known to have 
regulatory roles in the development of various parts of the body in vertebrates (Alappat 
et a/., 1999; Meijlink et a/., 1999). Studies of Alx-4 and Msx-2 knock out mice have 
displayed the importance of their roles in skeletal patterning, differentiation, and 
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growth. These mice had craniofacial, axial, and appendicular abnormalities among their 
many defects (Antonopoulou et al., 2004; Qu et al., 1997; Satokata et al., 2000). 
In humans, heterozygous loss-of-function mutations of either of these genes may 
result in defects of the skull vault in the form of enlarged parietal foramina (PFM) 
(Mavrogiannis et al., 2006). Typical PFM are bilateral oval or round openings in the 
parietal bones on either side ofthe posterior frontal suture (O'Rhailly et al., 1952). 
They are easily distinguished from the normally present minute foramina that blood 
vessels run through (Tubbs et al., 2003), and are a result of delayed ossification during 
rapid calvarial expansion (Antonopoulou et al., 2004; Satokata et al., 2000). Frequently, 
PFM can be traced back to a defect in infancy that extends between the anterior and 
posterior fontanelles; when this persists, it is termed cranium bifidum (CB) 
(Mavrogiannis et al., 2006). A bridge of bone usually develops along the midline, that 
creates two separate foramina, which usually decrease in size with age through 
circumferential bone growth Eventually, complete closure may occur, leading to clinical 
nonpenetrance (Mavrogiannis et al., 2006). 
D. Members of the TGF-beta superfamily and the regulation of cranial sutural 
fusion 
The TGF-~ superfamily includes several molecules that are involved in 
signaling and have vital roles in various processes throughout development, such as, 
embryogenesis, tissue formation, and wound repair (Gold et al., 1997; Kingsley, 1994). 
Some members of this family that have been found to be involved in cranial suture 
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development are the TGF-~ isoforms (1, 2 and 3), and Bone Morphogenetic Proteins 
(BMPs). 
l.BMP 
Previous studies have shown, that BMP4 is expressed in the sagittal suture 
mesenchyme and dura mater of embryonic mice (Kim et at., 1998). Further study of 
postnatal sutures showed that BMP4 protein is localized to the suture mesenchyme and 
osteogenic fronts in fusing posterior frontal and patent sagittal and coronal sutures 
(Warren et at., 2003). 
Since BMPs have been found in patent and fusing cranial sutures, Warren et al. 
screened for BMP antagonist mRNAs before, during, and after the period of expected 
suture fusion. They discovered the presence of Noggin in the patent sutures in all three 
of these periods and almost no Noggin expression in the fusing PFS as early as the time 
period prior to suture fusion (15d) (Warren et at., 2003). 
Takao et aI., was the first to demonstrate the function of Noggin as a BMP 
antagonist in cultured murine bone marrow stromal cells (Takao et aI., 1996). Noggin 
protein was found to bind BMP4 with high affinity and inhibit BMP4 activity by 
blocking its ability to bind to cognate cell-surface receptors (Zimmerman et at., 1996). 
Noggin was originally described in the Xenopus and was found to playa role in 
normal dorsal development (Smith and Harland, 1992). Further studies by Brunet et at., 
found that Noggin induces lateral mesodermal tissues to form more dorsal elements 
including muscle, heart, and the pronephros. In addition to these roles, they also found 
that Noggin was able to rescue dorsal patterning in ventralized embryos (Brunet et at., 
1998). 
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Many of the roles identified for Noggin, oppose those known for BMPs, for 
example, the role of BMP to rival ventralizing potential in a developing embryo. As a 
result of these studies, recent work has looked further into the roles of Noggin and 
suggested that it might play an important part in maintaining suture patency (Lenton et 
al., 2005). 
Recently, the BMP antagonist Noggin has been linked with FGF2 activity and 
determination of suture fate (Warren et al., 2003). Only the dura of the PFS expresses 
FGF2 mRNA and protein in vivo (Greenwald et al., 2000) and produces high levels of 
FGF2 in culture. FGF2 disrupts Noggin induction in a dose-dependent fashion, 
suggesting that environments with a high FGF2 concentration, such as the PFS, reduce 
Noggin expression and enable suture fusion (Warren et al., 2003). 
Further evidence which suggests that Noggin may be responsible in determining 
suture fate is the 3 day old CD-I mice injected with a noggin adenovirus that had 
widely patent posterior frontal sutures after 50 days (Warren et al., 2003). 
E. Transcription factors associated with BMP-Signaling 
1. DIx Genes 
Dlx homeobox containing genes are mammalian homo logs of the Drosophila 
Distal-less (Dll) gene. They are a group of six genes that are organized into pairs, 
specifically, Dlx 112, Dlx 5/6, and Dlx 317 (Robledo et al., 2002). Mammalian Dlx 
genes are expressed in the primitive craniofacial region, the developing brain, and 
limbs, as well as, the apical ectodermal ridge (Robledo et aI., 2002). Dlx gene products 
have a conserved 60 amino acid homeodomain and are members of a large family of 
14 
DNA-binding transcription factors. They are believed to control the transcription of 
genes that affect organogenesis for skeletal fonnation (Miyama et al. 1999). 
Dlx5 has been coined by some to be a new candidate responsible for skull 
fonnation (Depew et al., 1999; Acampora et al., 1999). Compared with their other 
family members, Dlx5 and Dlx6 are uniquely localized to all skeletal tissues (Holleville 
et aI., 2003). In fact, Acampora et al., found Dlx5 and Dlx6 in immature chondrocytes 
and developing skull bones of embryonic mice and rats and in the periosteum of more 
mature bones (Acampora et al., 1999). 
Results from several in vivo studies have provided evidence that indicates the 
involvement of the Dix family of hom eo domain proteins in the regulation of osteoblast 
differentiation and bone tissue-specific gene expression (Miyama et ai., 1999). Ryoo et 
al., showed that among the Dlx genes, Dlx5 is a bone-inducing transcription factor that 
is expressed in fetal rat calvarial cells in the later stages of osteoblast differentiation 
(Ryoo et al., 1997). In addition, it has been shown, that forced expression of Dlx5 in 
cultured cells leads to osteocalcin expression and a fully mineralized matrix (Lee et al., 
2003, Miyama et al., 1999, and Tadic et al., 2002). These results strongly suggest that 
Dlx5 plays an important role in the development of mineralized tissues. 
In an investigation of potential functional roles for Dlx5, Miyama et aI., isolated 
Dlx5 as a BMP-inducible gene by differential display technique. Subsequently, they 
demonstrated that mDlx5-transfected cells show a more mature osteoblast phenotype 
when compared to parental MC3T3-El cells, suggesting that mDlx5 plays a role in 
osteogenesis (Miyama et al., 1999). In the study, mDlx5-transfected cells showed higher 
alkaline phosphatase activities, osteocalcin production, and mineralization of 
15 
extracellular matrix, suggesting that mDlx5 is a positive regulator of osteoblast 
differentiation. 
In addition, when the time course ofmDlx5 mRNA induction ofMC3T3-El 
cells was examined, transcripts of mDlx5 continuously occurred 48h past the time of 
BMP treatment. It was proposed from these findings, that the mDlx5 gene product plays 
an important role in the later stage of the differentiated osteoblast since osteoblast fate 
has been clearly determined at this time (Miyama et at, 1999). 
Recent investigations, showed that Runx2, a transcription factor that plays an 
essential role in osteoblast differentiation and bone mineralization (Lee et al., 2005), as 
well as alkaline phosphatase (ALP) expression, was induced, in the absence ofBMP-2 
with forced expression ofDlx5 (Kim et al., 2004). Another fmding was that blocking of 
Dlx5 completely inhibited BMP2-induced stimulation ofRunx2 and ALP expression. 
These results proved, that Dlx5, is required as an upstream regulator of the expression 
of Runx2 that is generated by BMP signaling and suggested that Dlx5 enhances ALP 
expression by increasing Runx2 expression (Kim et al., 2004, and Holleville et 
al., 2007). 
Results of these studies have shown that Dlx5 is essential for BMP-mediated 
osteoblast differentiation and have suggested that Dlx5 plays a role in the mature stages 
of mineralization in skeletal tissue. These, and previous findings linking BMP signaling 
to murine PFS fusion, in addition to its expression in developing (Kim et al., 1998) and 
adult cranial sutures (Warren et al., 2003), has lead us to believe that Dlx5 may play an 
important role in cranial suture fusion. 
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Abstract 
Biglyc.n (Bgn) and decorin (Ocn) arc highly expressed in numerous tissues in the craniofacial complex. However, their expression and 
function in the cranial sutures are unknown. In order to study this, we first examined Ihe expression ofbiglycan and deeOl;n in the posterior irontal 
suture (PFS). whicb predictably fuses between 21 and 45 days post-natal and in the non-fusing sagi1tal (S) suture from wild-type (WI) mice. Our 
data showed tbal Bgn and Den were expressed in bolh cranial sutures. We Lhen characterized the cranial suture phenotype in Bgn deficient, DCIl 
deficient, BgllIDcl1 double deficient, and Wt mice. At embryonic day 18.5, alizarin red/ale ian blue stain ing showed !bat !be Bgn/DclI double 
deficient mice bad hypomineralization of the trontal and patietal cmniofacial bOlles. Histological analysis of adult mice (45- 60 days post,natal) 
sbowed that the Bgn or Den deficient mice had no cranial sutUl'e abnormalities and immunohistochemistry staining showed incrc.1scd production 
of Den in the PFS from Bgll deficient mice. To test possible compensation of Den in the Bgn de1ieient sutures, lVe examined the BgllIDcll double 
deficient mice and found that they had impaired fusion of the PFS. Semi-quantitative RT-PCR analysis of RNA from 35 day-old mice revealed 
increased expression of Bmp-4 and Dlx-5 in the PFS compared to their non-fusing S suture in Wt tissues and decreased expression of Dlx-5 in 
both PF and S sutures in the Bgll/DclI double deficient mice compared to the \Vt mice. Fai lure of PFS fusion and hypomineralization of the 
calvaria in the BgnlDcn double deficient mice demonstrates that these extracellular matrix proteoglyeans could have a role in controlling the 
formation and growth of the cranial vault. 
~";l 2006 Elsevier Inc. All rights reserved. 
Keyword.,: Small proteoglycans: Biglycan; Decorin; Crania l suture; Mouse 
Introductiou 
Biglycan (Bgn) and decorin (Dcn) are members of the small 
leucine repeat proteog1ycan family (SLRP). Members of this 
family are characterized by a small protein core, which consists 
predominantly of leucine,rich repeaL~. There arc 13 known 
members of this family that are divided into three classes 
depending on their genomic organization and the similarity of 
their amino acid sequences. Bgn and Den belong to the class I 
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type SLRP and are highly expressed in skeletal and connective 
tissues [1 , 12, 14, 15.31]. The exact function of both Bgn and Den 
is unknown; however, both can bind and modulate members of 
the TGF-beta superfamily [II]. 
Bgll deficient mice have impaired post,nalal bone fonllation 
which may be due to the ability of Bgn to modulate the actions 
of Bone morphogenic proteins,214 (B1l1p,2f4) in osteoblastic 
cells, potentially contributing to the failure to achieve peak bone 
mass and early onset of osteoporosis [4,36]. Den deficient mice 
do !lot have obvious skeletal defects, but instead, have skin 
fragility which is hypothesized to be due to tile ability ofDcn to 
modulate collagen fibril structure and intcgrity [7]. Because of 
their similarity ill structure and tlleir overlapping expression in 
skeletal and connective tissues, it is probable that Bgll and Den 
862 S, Wadhwa et ai, i Bone 40 (2007) 861-866 
fimction redundantly. Support of this concept comes from the 
analysis of Bgl/IDcl/ double deficient mice that have a more 
severe phenotype in both long bone and skin [25] compared to 
WI or singly deficient SLRP mice. 
The purpose of this study was to examine the role orBgu and 
Den in the craniofacial complex. In the craniofacial region, Bgn 
and Den are present in teeth [22,28], periodontal tissues [21]. 
nasal cartilage [29], eye [8]. temporomandibular joint [18], the 
developing mandible [16,35]. and tbe developing calvaria [35]. 
Despite their prevalence in numerous tissues of the craniofacial 
complex, little is knowl] about their function in these tissues. In 
order to examine this furlher and to eliminate potential 
compensation of Den with Bgn, we examined whether a 
craniofacial phenotype could be unmasked by creating Bgl// 
Den double deficient mice and comparing thera to the single Bgn 
deficient, single Dell deficient, and control Wt miee. 
There is similarity and conservation in the molecular 
pathways thai control the assembly and growth of the cranial 
vault between humans and mice [33]. In mice. all the cranial 
vault sutures remain opcn throughout the life span ofthe animal, 
except for the posterior frontal suture (PFS), which fuses in a 
predictable fashion between 21 and 45 days post-natal (25]. In 
hltnlanS, the equivalent metopic suture fuses within the first 3 
years post-natal [30,34]. Therefore. the mouse PFS serves as a 
model of post-natal human sutuml growth [33]. Bmp-2f4 
signaling has been linked to murine PFS fusion by Warren el al.. 
who showed that inhibition of the BnIP-2!4 signaling pathway 
by adenovirus mis-expression of the Bmp antagonist Noggill 
blocks mllfine PFS fusion in vivo [32]. Since both biglycan and 
deeorin can modulate Bmp-2!4 signaling, we hypothesized that. 
in their absence, there would be defective Bmp-2/4 signaling 
and impaired PF sutlU1l1 fusion. 
In this study, we found that Bgn and Den were expressed in 
the fusing PFS and in the lion-fusing S suture in Wt mice. The 
PFS in hoth Den deficient and Bgn deficient mice revealed no 
defects. However, further examination of the PFS in the Bgn/ 
Dell double deficient mice showed a lack of PFS fusion ill a 
mechanism that is potentially related to a decreased expression 
of Dlx-5. 
Experimental procedures 
GeJ1(ffation of Bgn and Dell single and double deficient mice 
All experiments were performed under an instilulionaUy approved protoC{)] 
for the use of animals in research (IiNIDCR-lRf'·98-0S8 and 01-151). Mice 
deficient in Bgn and Den were generated by gene targeting in embryonic stem 
cells as de=ibed previously [7.36]. Heterozygous 8gn!Dcn deficient mice were 
produced by breeding a homozygous Bgn deficient female (B15Il-I-IDcn+I+) 
with an Den deficient male (Bgll+I/iIDcIl+/-); deficient 
males are since the Bgn gene is located chromo-
some and absent from the Y chromosome, F2 BgnlDen double deficient mice 
were obtained by interbreeding Fl heterozygnus BgnJDeI/ deficient animals, In 
order to maximize the number ofrlouble deficient mice obtained, the following 
breeding scheme was tilled: Bgll O/-IDw+/- males were bred to BI,,'ll +/-IDcn+/-
females, The crauial vault "fthe mice was analyzed at embryonic day 1&.5. and 
post-natal days 35, 42, and 60, We chose to examine 42 days and 60 days post-
natal (Ill. posterior frontal SUIllre normally fuses hetween 21 and 4S days post-
natal) hecause they represent time points during and well past normal PFS 
closure which allowed us to evaluate ifthere was a delay or failure "fPFS fu,im> 
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in the transgenic mice. We selected post-natal day 35 for our RT-l'CR analysis 
because we wanted to evaluate whether there would be differences in gene 
""pres.sion during the time of normal posterior frontal sutural fusion. 
Gellotyping 
All mice were genotyped for Bgn and De" alleles by PCR aualysis as 
described [5], PeR products were resolved by electrophoresis through 1.8"1. 
agarose gels. yielding bands of 212 bp for the WI Bgll allele, 310 bp for the 
disrupted B15I1 allele. J61 bp for the WI Dell allele, and 2.~8 bp for the disrupted 
Dell allele, 
Alizarin red and alcUm bille staining of mice littermate., 
In our experimeJ1lal "I'Pmach, we used a breeding scheme that would 
maximize the number of BgnJDcn double deficient mice, and lOr this reason, 
we were ullable to obtain a humo:zygous WI mouse and BgllIDcn double dell· 
cient mouse in the same liner. Therefore, hI this first part of the study. We used 
(Bgn+!-iDcn+/+) mice as our controls. 18.5 d.r.c. linenn.les obtained from 5 
litters were euthanized, and then their skin, muscle, and fat were =ved. The 
animals were fixed in 100% ethanol for 4 days and then placed in _cerone for 
3 days. Mice were tben stained with alizarin red (0,09%) and aleian blue (0.05%) 
in a solution com.ioing ethanol, glacial acetic acid, and water (67:5:28) for 
3 days. After staining, mouse samples were transferred to 1% KOH until their 
soft ,issues were dissolved and then preserved in a 100% gtycerol [23]. 
FuxiJroll 
Sixty day.old mice were divided inlo four groups. WI. Bgll defICient, Den 
deficient and Bgn/Dc'11 double deficient, "ith 3n 11 ~ 3 for each group, The mice 
were sacrificed and the soft tl",ues on their heads were removed. The calvaria 
were radiographed using a Faxitron MX-20 Specimen Radiography System 
(Faxitron X"ay ('.orp., Wheeling. II... USA) al an energy of90 kV for 20 s. The 
images were captured with Eastman Kodak ('.0. X-OMAT TL (Eastroan Kodak 
('0., Rochester, NY, USA). 
In order to detennine the optimal length of a rectangular box that could be 
used to quantitate the amount of radio-opacity in the PFS. the length of the PFS 
from 60 day-old WI, Bg/l deficient, Den deficient, and Bgn!De/T double deficient 
mice wu, firsl measured. The mean length±the standard elTor of the PFS was 
I 1.0",0,6 mm forWt, IOJ±O.3 mm from BglI deficient. JO.7±1.2 mm fromD"/t 
deficient, and 11.1±0.3 mm foc Bb~liDc'11 double deficient mice. Evaluation of 
diffurences among the memlS by analysis of variance (ANOVA) reve-aled that 
there were no significant differences in the len gth of the PFS between the groups. 
Therefore. a 10 mm by 3 mm rectangular box was used to measure the amount of 
radio-opacity in the PFS from the different gmups, The amount of radio-upacity 
in the PFS was quantitated by using Image J NIH IMAGE. 
Histology alld immunohistochemistry 
WI. Dell deficient, Bgn deficient, and Bg/riD!" douhle deficient ntice were 
sacrificed by CO2 inhalation at 35-45 days al\er birth, Calvaria were removed 
and fixed for 2 weeks at room temperature in 10% IOmllllin. After being wasbed 
in water for 5 min, they were decalcified in ronnie acid bone decalcifier solution 
([mmunocal from Decal Corporation, Tallman. NY, USA) for 4 weeks. 
Specimens "' ..... II,en washed in water for 5 min and fixed for 3 days in butTered 
zinc fonn.lin (Z-fiJ( from Anatech Ltd., Battle Creek. MI, USA) before being 
classically processed for histology and sectioned coronally. Section. were stained 
withH&E. 
Tissue sections were deparaff'mized with xylene. Following rehydration with 
decreasing ooncenlrolionsof ethanol. the sections wefI'lreated with 3% peroxide in 
methanol fur20min loblockendogenous peroxidase activity. Iuordertoexposethe 
antigen, section. were predigested in chondroitina", ABC (cat# KEOI502, 
SeikagakuCorp, Tokyo, J."an) ata concentration of 0.015 unilslmlrorl bOI37"C. 
Incubating the sections in 10% gnat serum fur 30 min reduced non-specific binding, 
Sections were then incubated overnight at 4 0(' with primary antibody at a 1:200 
dilution. Den and Bgn antibodies (respectively LF 113 and LF 106) were kind gift. 
from Larry Filiher(NIOCR. NIH~ Biotinylated rabbil anti-goat secondary antibody 
S. Wadlnva e/ at. / BOlle 40 (2007i 86J~66 863 
was used and visualized by a slrept.vidin- peroxidase solution io !he presence of 
DAB chromagen. The negative control consisted of the above mentioned 
procedures except for the substitution of the primary antibody with rabbitlgE. 
The data presented in this paper were reproduced in at least 6 different 
sections from two separate animals for each group. Serial sections through the 
whole suture were obtained for each animal and observations were confirmed in 
different interspaced serial sections chosen to coverlhe whole suture. In this way. 
it was ensured that the reported observations were genuine and not local random 
abnonnalities. ln each case, data from a single representative experiment are 
shown. 
isolalioll oflhe sulu,.e complexfor mRNA extraction 
Posterior frontal (PF) and sagittal (S) suture complexes (including the 
associated dura mater, suture mesenchyme~ and osteogeJJic fronl<;) were 
harvested from 35 day-old male Wt (11 = 4) and BglI/Dc/l (11 = 2) double deficient 
mice. Mice were eutb3Dized with carbon dioxide, and the posterior frontal and 
sagittal suture complexes were isolated under a dissecting microscope as 
previously described [241. 
Semi-qual1litalive RT-PCR 
RNA was extracted from the cranial suture material using Trizo.l·Reagent 
(Molecular Research Center. Cincinnati, OH) following the manufacture's 
instructions. One microgram total RNA from the sample preparation was reverse 
transcribed with 50 units of SuperScript II RT usillg random hexamer primers 
(lnVitrogeo Life Technology, Carlsbad, CAl following the manufacturer' s 
instructions. The primers used for amplification were designed with Primer 3 
software (http://www-genome.wi.mit.eclu/cgi-binlprimeriprimer3.cgi). The pri-
mers used for RT-PCR were for Gapdh 5'gagaggccetatcccaact3' (forward) 5' 
gtgggtgcagcgaacUtat3'(reverse), for Bmp-4 5'ggtgggtttgcttccactta3' (forward) 
and 5'atgggagcgagttgtgtacc3' (reverse), for DL<-5 5'ccgggacgctttaltagatg3' 
(forward) and 5'tggacactatcaatggtgcc3' (reverse), for biglycan 5'acctgtcccct-
tecatctct3' (fonvard) and 5 'ccgtgtgtgtgtgtgtgtgt3' (reverse), for decorin 5 ' ccoac· 
ataactgcgatccct3'(forward) and 5'tgtccaagtggagucccte3'(reverse), and for l8s 5' 
catgtggtgtgaggaaa3'(fOlward) and 5'gcccagagactcatttctt3'(reverse). J'CR was 
performed using a hot start (with Taq Gold™, Applied Biosystems) at 95 'c for 
10 min followed by 45 cycles (biglycan. decorin, 18s. and GAPDH) or 50 cycles 
(Dlx-5 and Bmp-4) of I on," at 94 "C,20sat 57 'Caod 30s at 72 'C followed by 
a 7 min extension at 70 "C. The reaction was chilled to 4 'C afterwards until it 
was analyzed. Sixteen microliters of the PeR product and a I OO-bp DNA ladder 
(Gibco BRL) were run in a 10% acrylamide gel (THE) buffer at 100 V. The 
products separated by electrophoresis were visualized after ethidiuon bromide 
staining under a UV light aod photographed in a single field of view with a 
digital camera. IndiVIdual bands on digital micrographs of RT-PCR products 
were analyzed by densitometer using ImageJ NlH IMAGE Intensity for Dl,·.5, 
Bgn. Den. and Bmp-4 was calculated as a percentage of densitometry values for 
control bands of GapdJr or 18s. Each primer set was tested previously to assure 
that amplification was in the linear range by analyzing amplification af several 
different cycle numbers . 
Statistical analysi" 
Statistical significance of differences among means was detennined by 
analysis of vanance (ANOVA) wid! post hoc comparison of more than two 
means by the Bonferroni method using GraphPad Prism (San Diego, CAl. 
Results 
Alizarin red- alciall blue staining oj E 18.5 /itlermates 
Alizarin red-alcian blue staining ofE 18.5 control (Bgn t / ! 
DCI/+ it) was used as the control due to the inability to generate 
a Wt and a BgnlDcn double deficient in the same litter) and 
BgnlDcn double deficient littcnnales revealed that the Bgnl 
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DCII double deficient embryos had severe hypominera1ization of 
the Ji'ontal and parietal bones (Figs. I A-D). Alizarin red and 
alcian blue staining were also performed on two additional BglI/ 
Dell double deficient embryos along with two littermate 
controls revealing similar results (data not shown). 
Expression of Bgn alld Den ill the PFS aJ/d sagiJta/ su/ure /iom 
WI mice 
A time course for the expression of Bgn and Den was 
determined in the PF and the S suhtre in WI mice at day 21, day 
25, and day 35 post-natally by semi-quantitative RT-PCR. The 
data indicated that mRNA encoding both biglycan and decorin 
is abundantly expressed in both the posterior frontal and sagittal 
suture during maruration (Fig. 2A). Since there appeared to be 
increased expression of BglI mRNA in the PF compan:d to the S 
sutnre during the late phases of PFS fusion. we repeated Ihe 
cxpelimCllts two more times at day 35 post-natal. In the three 
independent experiments from 35 day-old Wt mice, we found 
that the ratio of Bgn mRNA expression in the PFS/S suture was 
l.l ±O.3. 
[n order to dctennine the precise localization of Bgn and Den 
protein expression in the PFS and to evaluate possible 
compensation at the protein level, immtUlohistochemistry for 
Bgn and Den was pelfollUed in 42 day-old Wt and Bgo 
deficient mice (Figs. 2B- E). [n the PFS from the Wt and Bgn 
deficient mice, Den was found in the underlying dura (Figs. 2e, 
E). [n the Wt mice, Dcn appeared to have a more restricted 
A B 
Control BgnlDcn DKO 
c D f,ontal 
~ fr~ parietal &I' 
Control 8gnlDcn DKO 
Fig. I. Alizarin red/a leian blue 'taining of E18.5 littermates. (A. C) Control 
BgII+I-/DcII+/+ mice. (8, D) Bb~';Dm double deficient mice. 
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Fig. 2. Expression ofBgn and Den in cranial sutures. (A) Semi-quanlilative RT-
PCR analysis perfonned [or DCIl and Bgn on RNA extracted from the sagittal 
(S) suture and Ihe posterior frontal suture (PFS) from 21,25. and 35 d.y-old 
wild-type (Wt) mice. (B-E) Immunohistochemistry (brown) for biglycanlB. D) 
and decorin (C, E) on coronal sections of the posterior frontal suture from 
42 day-old Wt (B, C) and Bgll deficient mice (0. E). Sections were 
counterstained with hematoxylin (blue). 
expression pattem in the dura compared to BglI deficient mice 
where it was found at a higher level and Ihroughout the 
structure. In contrast, the PFS from the Dcn deficient mice had 
no change in the localization of 8gn in the underlying dura 
compared to Wt mice (data not shown). Negative controls 
consisting of the substitution of the primary antibody with 
rabbit IgE revealed no visible staining (data not shown). 
Ana(vsis of the PFS jivm Bgn dejicient. Dcn deficient, BgIIIDcf/ 
Double deficient and WI mice 
Tn order to detennine what role 8gn and Den deficiency 
had on latcr developmental stages. 60 day-old Wt and Bgnl 
Dcn double deficient mice were examined. Faxitron analysis 
showed that the Bgn/Dcn double deficient mice had a clear 
absence of radio-opacity in the PFS. On the other hand. 
calvaria obtained from 60 day-old Wt, Bgn deficient. and 
Dcn deficieut mice, all had PFS that was radio-opaque (data 
not sho\>,'I\). Quantification of the amount of radio-opacity in 
the PFS by X-ray scanning and NIH-image analysis revealed 
that it was significantly decreased in BgIIIDcll double 
deficient mice compared to the other groups (p< 0.001) 
(Fig. 3A). Besides a decrease in mineralization of the PFS. 
the decrease in radio-opacity in the PFS from tlle BgIIIDclI 
double deficient could also be due to a difference ill the 
structure and curvature of the calvaria. To test this 
possibility. coronal histological sections of the PFS from 
45 day-old Bgn deficient (Fig. 3C), DCIl deficieut (Fig. 3D), 
Bgn/Dcn double deficient (Fig. 3E), and Wt mice (Fig. JB) 
were examined. This analysis revealed PFS patency only in 
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Fig. 3. Analysis of radio-opacity and histology of the PFS from Wt. BglI 
deficien~ DCII deficien~ and Bgl//Dcl/ double deficient mice. (A) Quantifica-
tion of intensity of radio-opacity in lbe PFS from faxitron images of the 
calvaria from 60 day·old WI. Bgl/ deficient. Dw deficient, and Bgll/ Dcl/ 
double deficient mice. Each point is the mean and SEM for 11 = 3 for each 
group. 'Significant decrease in the intensity of radi<Hlpacity in the PFS from 
the BgnlDcl/ double deficient mice compared to the other groups. p > O.OOI. 
(B-E) H&E staining of corona l sections of the posterior frontal suture from 
45 day-old Wt IB), BgJl deficient (C). Dw deficient (0), and Bgl/lDcl/ double 
deficient (E) mice. 
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Fig. 4. Semi·quantitative RT-PCR perfonned for Bmp-4 and Dlx-5 on RNA 
extracted from the sagiu.1 (S) suture and the posterior frontal suture (PFS) limn 
35 day-old wild-type (Wt) and BgJlIDclI double deficient mice. RT-PCR of 
Gapdh served as a Ilonnalizing control. 
£>;pressioll ofBmp-4 alld Dlx-5 mRNA in PFS alld sagittal 
suture from 35 day-old WI alld BgnlDcn double deficient mice 
Because Bmp-2/4 signaling has been previollsly implicated 
in controlling PFS fusion [32], we examined the relative 
expression levels ofBmp-4 mRNA, and the Bmp-4 target gene, 
Dlx-5 mRNA [10], in our mouse model. Messenger RNA was 
extracted from the fusing PFS and non-fusing S sutures of 
35 day-old Wt and in BgnlDcl1 double deficient and analyzed 
by semi-quantitative RT-PCR These analyses showed that 
Bmp-4 mRNA levels were higher in the (fusing) PFS compared 
to S suture in both genotypcs. Intcrestingly, whcn Dlx-5 was 
measured in the same samples, it was significantly highcr in the 
Wt PFS compared to the S suturc but absent in both Sand PF 
sutures in BgnlDcn deficient mice (Fig. 4). Similar results were 
obtained in a second independently repeated experiment (data 
not shown). 
Discussion 
This report shows that both biglycan (Bgn) and decorin (Dcn) 
are abundantly expressed in the cranial sutures of mice, with 
overlapping yet distinct pattems of expression in the fusing 
suture and the dura maIer. We found that BglllDc1/ double 
deficient mice have open sutures and severe hypomineralization 
of both frontal and parietal bones as early as E 18.5, while mice 
singly deficient in Bgll or DCII have no suture fonnation defects. 
Murine PFS fusion is controlled by a complex interaction 
between many different types of cells, tissue types, and growth 
factors. For example, Warren et a!. [32] has proposed that Fgf-2 
secreted by the underlying dura causes a downregulation of 
Noggin within the posterior frontal sutural cells that allows 
Bmp-214 to interact with the bone fronts to cause fil~ion of the 
PFS. For such orchestration of events to occur. therc must be 
control of the localization and activity of the secreted growth 
factors. Proteoglycans that could modulate the activity of 
growth factors within thc extracellular matrix of the posterior 
frontal suture may providc this control [26]. 
Scverallines of evidence link both Bgn and DCll to Bmp-2/4 
activity. III a recent study, we found that Bgll deficient calvarial 
osteoblast-like cells had less ccll surface Bmp-4 binding, which 
led to reduced Bmp4 mediated osteoblast differentiation in 
Bgl/ deficient calvarial osteoblast-like cells compared to Wt 
controls [4]. Similar results have been noted in MC3T3-EI cell-
derived clones expressing higher or lower levels of biglYC3n 
[27]. Den has been shown to modulate the actions ofBmp-2/4. 
Specifically Bmp-2 induction of alkaline phosphatase was 
diminishcd in DCII deficicnt myoblast cells compared to Wt 
controls [9]. 
Bgo and Dcn are similar in structure and function and it is 
possible that they function redundantly. Immunohistochemistry 
revealed tllat, in the absence of Bgn, Den is upregulatcd 
throughout the PFS. Dcn expression was restricted to the interior 
portion of the dura in Wt mice but more evenly distributed 
throughout thc underlying dura of the PFS in Bgl/ deficient mice. 
We have also previously reported increased expression of Den in 
Bgn deficient osteoblastic cell cultures [4]. Furthermore we 
found that the ability of Bmp-2 to induce mineralization, as 
measured by alizarin red accumulation, was decreased 52% in 
osteoblast-like cells from BgnlDcll double deficient mice [2] 
compared to 30% in Bgl/ only deficient osteoblast-like cells [4]. 
We hypothesize that the impaired PFS in the BgnlDcl1 
double deficient mice is due to altered Bmp-4 signaling sincc 
we found equivalent mRNA expression of Bmp-4 but marked 
reduction of Dlx-5 expression in the BgnlDcII double deficient 
cranial sutures. Many extracellular and intracellular proteins. 
such as Dlx-5, regu1ale the Bmp-2/4 signaling pathway. 
Specifically. Bmp-2/4 has been shown to increa~e Dlx-5 
cxpression in avian calvarial explant cultures [13] and in 
osteoblastic cell cultures [10]. In addition, the Bmp-2!4 
regulation of the osteoblast differentiation markers, RUIlX-2, 
Osterix, and Alkaline phosphatase, appears to be dependent on 
Dlx-5 [17,19.20]. Impaired PFS fusion in the BgnlDcn donble 
deficient mice may be due to failure of appropriate cxpression 
of signaling molecules involved in promoting bone formation 
and mineralization, which is consistent with previous findings 
of severe osteopenia [2,5] and decreased expression ofDlx-5 in 
the cranial sutures. However, as has been suggested by others, it 
is important to consider the possibility that additional factors 
besides increased or decreased bone formation could control 
abnonnal cranial suture fusion [3,6]. 
Table ! 
Summary of craniofacial anomalies in BglI. DCII, and BglI/DclI deficient mice 
compared to Wt 
Genotype E 18.5 Post-natal Suture gene/protein 
calvaria PF fusion expressjon 
Wt Nonna! Nonnal DIx-5 and Bmp-4 mRNA 
higher in PF vs. S 
BgII deficient ND Nonnal Den protein higher 
in Bgn deficient 
D ell deficient NO Nonnal Bgll protein unaffected 
BglIIDcn deficient Hypomineralized Patent suture Dlx-5 mRNA absent in 
PF and S sutures 
Nonna! WI mice and mice deficient in Bgn, Den, or both (genotype, column I) 
were analyzed at embryonic day 18.5 (E 18.5) by alizarin red/alcian blue 
staining (column 2) or post-natally (60 days after birth) by faxitron X-ray or 
histology (column 3). Specific mRNA or protein .xpression in the normal and 
mutant mice wa' examined in PF (posterior frontal) or sagittal (S) sutures 35-
45 days after birth (colwun4). ND~not detennined. 
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In conclusion, we show that the alteration in the extraeellular 
matrix of the posterior frontal suture causes impaired fusion 
(Table I). These new data provide the fOlmdation for the 
identification of novel candidate genes for patients who have 
sutuml growth disturbances, 
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Introduction 
There are two main types of cranial suture growth disturbances. Too little or 
delayed bone growth at these sutures results in wide-open fontanels and a human 
disease known as enlarged parietal formania, whereas too much or accelerated bone 
growth results in osseous obliteration of the sutures, and the human disease 
craniosynostosis (Opperman 2000). 
We have previously reported that in mice deficient in both biglycan and decorin, 
there is lack of PFS fusion at 60 days. Analysis of gene expression in the PFS from 35 
day-old wt and double deficient biglycanJdecorin mice, revealed equivalent expression 
ofBMP-4, but a marked decrease in the expression of Dlx5 in the double deficient 
mice. Therefore, we hypothesized that Dlx5 plays a role in PFS fusion. In order to test 
this hypothesis, we examined the expression of Dlx5 in the cranial sutures from CD-l 
mice and examined if a cranial suture phenotype was present in Dlx5 mIce. 
In this study, we found that Dlx5 is abundantly expressed in both the sagittal and 
PFS between 10 and 35 days postnatal. There was an increase in the expression of Dlx5 
in the PFS compared to the sagittal suture at day 35. Examination of the cranial sutures 
from Dlx5 +1- mice revealed no defects in PFS fusion, but instead an increase in the 
distance between the parietal bone fronts in the sagittal suture. Taken together, these 
results suggest that Dlx5 plays a role in postnatal growth of the sagittal suture in CD-l 
mIce. 
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Materials and Methods 
To develop the mouse model for mice used in our experiments, Dlx5 transgenic 
mice (Obtained from Dr Alex Lichler, UCllC, Farmington, CT) were bred with mice 
transgenic for the 2.3 kb fragment of the collagen Type I promoter fused to a Green 
Fluorescent Protein (2.3 GFP) (Obtained from Dr. David Rowe, UCHC, Farmington, 
CT). The specific breeding pairs were Col I 2.3 GFP (+1+) Dlx5 (+1+) with 
heterozygous Dlx5 (+1-), and Col 12.3 (+1+) heterozygous Dlx5 (+1-) with Col 12.3 
GFP (+1+) Dlx5 (+1+). Heterozygous Dlx5 (+1-) 2.3 GFP (+1+) and homozygous Dlx5 
(+1+) 2.3 GFP (+1+) littermates were analyzed. 
Genotyping 
All mice were genotyped for Dlx5 alleles by polymerase chain reaction (PCR) 
analysis as described previously (Depew et a1. 1999). PCR products were resolved by 
electrophoresis through 1 % agarose gels, yielding a 368 bp band for the wt Dlx5 allele 
and a 459 bp band for the disrupted Dlx5 allele. PCR products were visualized by 
ethidium bromide staining under an ultraviolet light 
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Histology and Immunohistochemistry 
Frozen Embedding 
Wild-type and heterozygous Dlx5 (+/-) mice were sacrificed by CO2 inhalation 
at 10 days after birth. Calvaria were removed and fixed for 2 weeks at room temperature 
in 10% formalin. Next, they were separated into posterior frontal and sagittal regions 
and placed in separate cassettes. After a 5 minute water wash, they were decalcified in 
formic acid bone decalcifier solution (Immunocal from Decal Corporation, Tallman, 
NY, USA) for 4 weeks. Specimens were then washed in water for 5 minutes and fixed 
for 3 days in buffered zinc formalin (Z-fix from Anatech Ltd, Battle Creek, MI, USA). 
Prior to embedding, a 200mI beaker containing 2-methylbutane was pre-chilled 
over dry ice under a hood. Disposable base molds (Thermo Shandon) were filled with 
frozen embedding medium (Thermo Shandon), care was taken to avoid the introduction 
of bubbles. Posterior frontal and sagittal suture regions of the calvariae were immersed 
in individual molds containing the embedding medium. The embedding media was flash 
frozen by holding the mold with forceps in a solution of 2-methylbutane keeping the 
embedding mold on a horizontal level. Once the medium was frozen, the mold was 
allowed to sink to the bottom of the beaker until it was completely frozen. The molds 
were removed from the methyl butane solution and wrapped in a square of aluminum 
foil, placed in a plastic container, and stored at -20°C. 
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CryoJane Frozen Section 
Cryosectioning was perfonned on a Leica CMl900 Cryostat (D-69226; Leica, 
Inc., Nussloch, Gennany) equipped with CryoJane Frozen Sectioning Kit (Instrumedics 
Inc.; Hackensack, NJ). The CryoJane system is designed to capture a frozen cryostat 
section on special cold adhesive tape to assist transferring the section to a cold glass 
microscope slide coated with an ultraviolet light-curable, pressure-sensitive adhesive. 
The section is pennanently bonded to the adhesive on the slide with a flash of 
ultraviolet light. 
The block containing either the decalcified posterior frontal or sagittal suture 
was oriented in the block holder to obtain a 5-~ coronal section. After capturing the 
frozen section on a piece of cold tape, the section was transferred to the cold slide, and 
the transfer tape was removed, leaving the frozen section behind on the microscope 
slide. The slides were air dried in the dark and kept in a slide box at 4°C before 
process mg. 
Fluorescent Imaging 
Slides holding the frozen sections were soaked in IX PBS for 20 minutes then 
mounted with cover slips using 50% glycerol in PBS. Col I 2.3 GFP was examined with 
a microscope under ultraviolet light and pictures were taken with a color digital camera 
at lOX magnification. 
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Immunohistochemistry 
Tissue sections were deparaffinized with xylene. Following rehydration with 
graded ethanol, sections were treated in 3 % peroxide in methanol for 20 minutes to 
block endogenous peroxidase activity. Next, sections were incubated in 10% goat 
serum for 30 minutes to reduce non-specific binding and incubated overnight at 4° C 
with primary antibody at a 1: 200 dilution. Dlx5 antibody was purchased from 
Chemicon (Temecula, CA) cat #AB5728 and Biotinylated rabbit anti-goat was used as a 
secondary antibody. Immunostaining was visualized by a streptavidin-peroxidase 
solution in the presence of DAB chromagen. The negative control consisted of the 
above mentioned procedures except for the substitution of the primary antibody with 
rabbit IgE. 
Semiquantitative RT-PCR 
Posterior frontal and sagittal suture complexes, including the associated dura 
mater, suture mesenchyme, and osteogenic fronts, were harvested from male wt mice. 
Mice were euthanized with carbon dioxide, and the posterior frontal and sagittal suture 
complexes will be isolated under a dissecting microscope as described by (Nacamuli, 
Song et al. 2004). RNA was extracted from the calvarial sutures using Trizol-Reagent 
(Molecular Research Center, Cincinnati, OH) following the manufacture's instructions. 
One microgram total RNA from the sample preparation was reverse transcribed with 50 
units of SuperScript II RT using random hexamer primers (InVitrogen Life Technology, 
Carlsbad, CA) following the manufacturer's instructions. The primers used for 
amplification were designed with Primer 3 software (http://www-
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genome.wi.mit.edulcgi-binlprimer/primer3.cgi). The primers used for RT-PCR were 
5' gagaggccctatcccaact3 ' (forward) 5' gtgggtgcagcgaactttat3 ' (reverse) for 18S, 
5' catgtggtgtgaggaaa3' (forward) and 5' gcccagagactcatttctt3 ' (reverse) for BMP-4, and 
5'ccgggacgctttattagatg3' (forward) and 5'tggacactatcaatggtgcc3' (reverse) for Dlx5. The 
reaction was chilled to 4°C until it was analyzed. Sixteen microlitres of the PCR 
product and a 100-bp DNA ladder (Gibco BRL) were run in a 10% acrylamide gel 
(TBE) buffer at 100 V. The products were separated by electrophoresis and visualized 
after ethidium bromide staining under a UV light then photographed with a digital 
camera. The R T -PCR procedure was repeated three times. Individual bands on digital 
micrographs of RT -PCR products were analyzed by densitometer using Image J NIH 
IMAGE. Intensity for Dlx5 and Bmp-4 was calculated as a percentage of densitometry 
values for control bands of 18S. 
Measuring the Width of the Sagittal and Posterior Frontal Sutures 
H & E stained coronal sections of the posterior frontal and sagittal sutures from 10 
day-old wt and heterozygous Dlx5 (+1-) mice were captured with a digital camera. In 
Adobe Photoshop the distance between the bone fronts was measured in arbitrary units. 
A micro-ruler was captured using the same digital camera, at the same magnification, 
and arbitrary units were converted to Ilm by measurement against a known distance. 
Statistical Analysis 
Statistical significance of differences among means was determined by analysis 
of variance with post-hoc comparison of more than two means by the Bonferroni 
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method or the Mann-Whitney rank sum test for nonparametric populations using 
SigmaStat (Jandel Scientific, San Rafael, CA). 
Results 
Dlx5 expression in cranial sutures 
Immunohistochemistry for Dlx5 was performed in 10 day-old CD-l mice. In the 
PFS from 10 day-old mice, Dlx5 expression was in the underlying dura and overlying 
periosteum (Figure lA). A similar expression ofDlx5 was noted in the S compared to 
the PFS (Figure IB). 
A time course for the expression of Dlx5 and BMP-4 was determined in the 
posterior frontal and sagittal sutures from CD-I mice at day 21, day 25, day 35, and day 
45 postnatally by semi-quantitative RT -PCR. The data indicated that mRNA encoding 
Dlx5 and BMP-4 were abundantly expressed in both the posterior frontal and sagittal 
sutures during maturation (Figure 2). Since there appeared to be an increase in 
expression ofDlx5 and BMP-4 mRNA in the PF compared to the S suture during the 
late phases ofPFS fusion, we repeated the experiments two more times at day 35 
postnatal. In three independent experiments from 35 day-old wt mice, the mean 
decrease and standard error of Bmp-4 mRNA expression in the sagittal suture compared 
to the PFS was 83 +/- 15%. Additionally, in three independent experiments from 35 
day-old wt mice, the mean decrease and standard error of Dlx5 mRNA expression in the 
sagittal compared to the PFS was 59 14 % (Figure 2 b). 
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Analysis of the Posterior frontal and Sagittal sutures from 10 day-old heterozygous 
Dlx5+/- andwt mice 
Mice deficient in both Dlx5 alleles die shortly after birth and have almost a 
complete absence of their calvaraie. In contrast, Dlx5 +/- heterozygous mice are viable. 
In order for PF sutural fusion to occur, the bone fronts of the frontal bone must come in 
contact with each other, which is expected to occur between 21 and 45 days postnatal. 
However, we have observed this process of suture fusion beginning at a time point prior 
to 21 days postnatal. Therefore, the cranial sutures from 10 day-old wt and Dlx5 +/-
were examined. H & E coronal sections of the Posterior frontal (Figure 3) and Sagittal 
sutures (Figure 5) revealed that there appeared to be greater separation of the bony 
fronts in the sagittal suture ofDlx5 +/- mice compared to wt mice. Measurement of the 
distance between the bone fronts of the Posterior frontal and Sagittal sutures from 10 
day-old wt (n=3) and Dlx5 mice (n=3), revealed a significant increase (p<.05) in the 
distance between the parietal bone fronts in the sagittal suture from Dlx5 +/- compared 
to wild-type controls (Figure 6). No significant differences were noted in the PFS 
suture (Figure 4), 
Osteoblast differentiation in the cranial sutures from 10 day- old heterozygous Dlx5 +/-
andwtmice 
Dlx5 has been show to mediate osteoblast differentiation (Ryoo et ai., 1997), 
therefore we hypothesized that there would be a decrease in osteoblast differentiation in 
the cranial sutures from Dlx5 mice compared to wt mice. In order to examine this, 
we bred Dlx5 +/- mice with mice transgenic for the 2.3 kb fragment of the collagen 
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Type I promoter fused to a Green Fluorescent Protein (2.3 GFP). Previous investigators 
have shown that the 2.3 GFP promoter is an accurate marker of differentiated 
osteoblastic cells (Kalajzc et al.,2002). We have initial histological sections of the PFS 
(Figure 7) and S suture (Figure 8) from 10 day-old Dlx5 +1+ 2.3 GFP and Dlx5 2.3 
GFP mice. However, we have not analyzed the samples. 
Discussion 
Our experiments show that Dlx5 is expressed both in the fusing posterior frontal 
and non-fusing sagittal sutures of mice during the time period of expected suture fusion. 
Holleville et al. found, in chick calvariae, that Dlx5 is highly expressed at the 
osteogenic fronts and at the edges of the suture mesenchyme, but not in the suture itself 
(Holleville et aI., 2003). Data from Acampora et aI., who studied mice, also indicated 
that the expression of Dlx5 was more pronounced in periosteal bone and was also 
observed in endosteal cells (Acampora et al., 1999). These findings are similar although 
some were found in chick embryos and others were found in mice. Our results also 
showed that Dlx5 was expressed in the osteogenic fronts as well as the periosteum and 
underying dura but not in the suture space. 
In this study, we chose to use heterozygous Dlx5 (+1-) mice to investigate the 
role ofDlx5 in cranial suture fusion due to previous findings that Dlx5 (-1-) mice are 
affected by a severe phenotype. Depew et al. found that Dlx5 (-1-) mutants die shortly 
after birth and approximately 25% of them are born exencepha1ic. The mutant mice 
born without exencephaly have hypomineralized parietals and interparietals and all of 
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the mutants had the phenotype of regional defects in their nasal and otic capsules 
(Depew et al., 2005). Our results lacked a distinct phenotype in the PFS of Dlx5 (+1-) 
mice. Previous reports from Depew et al. also recorded that no morphologic changes 
were noted with the loss of a single Dlx5 allele. Therefore, it is very possible that the 
phenotype of our heterozygous Dlx5 (+1-) mice was too mild for changes in fusion of 
the PFS to be visible. In addition, several studies have shown evidence which might 
suggest that other Dlx genes compensate when their family member is deficient. Dlx 
homeobox genes are organized into pairs as follows: Dlx1l2, Dlx5/6, and Dlx 
317(Robledo et al., 2002). Compared with their other family members, Dlx5 and Dlx6 
are uniquely localized to all skeletal tissues (Holleville et al., 2003). In fact, Acampora 
et al., found Dlx5 and Dlx6 in immature chondrocytes and developing skull bones of 
embryonic mice and rats and in the periosteum of more mature bones (Acampora et al., 
1999). Robledo et aI., 2002 showed that there are redundant roles for Dlx5 and Dlx6 
during osteogenesis in his study ofDlx5/6 (-1-) mice whose phenotype included a 
complete lack of calvarial bones. 
Developmental defects found in Dlx5 mutants that support our findings have 
been described by Depew et al. in 1999. Scanning electron microscope analysis ofDlx5 
homozygous mutant embryos revealed that a neural tube closure defect is centered in 
the midbrain but also includes the forebrain and hindbrain in the more severe cases. 
Examination ofthe calvarial roofs of non-exencephalic Dlx5 mutants revealed small, 
hypomineralized parietal and interparietals (Depew et al., 1999). This developmental 
phenotype, both in the specific areas of the brain, and in the parietal and interparietals 
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of the Dlx5 mutants supports our findings in the sagittal sutures ofDlx5 heterozygous 
(+1-) mice. 
Another possible reason for the lack of phenotype that was seen in the PFS but 
was seen in the sagittal suture from heterozygous Dlx5 (+1-) mice could be that PFS 
fusion is dependent in part on sox-9 expression and a cartilage template (Sahar et aT., 
2005). The role of Dlx5 in chondrocyte differentiation is different than that in bone, and 
this is why we propose that an obvious phenotype was not seen in the PFS. However, 
we did appreciate a phenotype in the sagittal suture ofDlx5 heterozygous (+1-) mice; 
this may be attributed to the lack of the necessity for a cartilage template in the sagittal 
suture and the role ofDlx5 in regulating osteoblast differentiation (Sahar et aT., 2005 & 
Ryoo et aT., 1997). 
We hypothesize that the phenotype observed in the sagittal sutures ofD1x5 (+1-) 
mice is due to a decrease in osteoblast differentiation compared to wt controls. In order 
to test this hypothesis, we bred Dlx5 (+1-) mice with mice transgenic for the 2.3 kb 
fragment of the collagen Type I promoter fused to a Green Fluorescent Protein (2.3 
GFP). The 2.3 GFP promoter has been shown to be an accurate marker of differentiated 
osteoblastic cells (Kalajzc et al., 2002). However, we have not analyzed the samples. 
Although craniosynostosis is a rare finding, it may cause severe malformations 
and developmental disorders in those that are affected. Since the genetic etiology is 
unknown in the majority of human patients with sutural growth disturbances, evidence 
that a Dlx5 signaling pathway is involved in cranial suture fusion, may provide a new 
candidate gene for analysis in patients with sutural growth disturbances. 
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The development of our knowledge of the genes involved in suture fusion is 
essential for progress in the medical and genetic treatment of individuals with cranial 




Previously, our lab studied PFS fusion in biglycanldecorin double deficient 
mice. In the study, we found that biglycan and decorin are highly expressed in fusing 
cranial sutures as well as the dura in overlapping but distinct patterns. The double 
deficient mice that were studied had patent sutures and severe hypomineralization of 
frontal and parietal bones. However, mice deficient with either biglycan or dec orin 
separately were absent of suture formation defects. 
Similar to Dlx5, both Biglycan and Decorin have been linked to BMP2/4 
activity. Recently, it was found that Biglycan deficient calvarial osteoblast-like cells 
have less cell surface BMP4 binding. This led to a decrease in BMP4 mediated 
osteoblast differentiation in the Biglycan deficient calvarial osteoblast-like cells 
compared to the wild-type controls (Chen et al., 2004). Similarly, Parisuthiman et al. 
found that MC3T3-E1 clonal cells expressing higher or lower levels ofbiglycan show 
less BMP4 mediated osteoblast differentiation (Parisuthiman et at., 2005). Decorin has 
also been shown to alter BMP2/4 activity. For example, Gutierrez et al showed a 
decrease in BMP2 induction of alkaline phosphatase in decorin deficient myoblast cells 
compared to wild-type controls (Gutierrez e aI., 2006). 
In this previous study, we hypothesized that the deficiency in PFS fusion that 
was observed in biglycanl dec orin double knock out mice was due to altered BMP4 
signaling because we found equal amounts of mRNA expression of BMP4 but markedly 
reduced expression of Dlx5 in the cranial sutures ofbiglycanldecorin double deficient 
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mice. This finding drove our interest in studying the role ofDlx5 in cranial suture 
fusion. 
Our experiments show that Dlx5 is expressed both in the fusing posterior frontal 
and non-fusing sagittal sutures of mice during the time period of expected suture fusion. 
Holleville et al. found that Dlx5 is highly expressed at the osteogenic fronts and at the 
edges of the suture mesenchyme, but not in the suture itself in chick calvariae 
(Holleville et al., 2003). Although we studied murine sutures, we also found that Dlx5 
was expressed in the osteogenic fronts as well as the periosteum and underying dura but 
not in the suture space. We also found that 10 day-old heterozygous Dlx5 (+/ -) mice had 
increased space between their bony fronts in the sagittal suture compared to wt controls, 
and that there was no apparent phenotype in the PFS from the Dlx5 (+/-) heterozygous 
mIce. 
Different models have been proposed in regards to the factors responsible for 
Dlx5 expression in cranial sutures (Figure 9). Choi et al. found that the addition of 
FGF2 to developing bone fronts in murine sutures stimulated BMP2 expression but that 
the addition of BMP2 could not induce FGF2 expression. Another finding, was that 
disruption ofRunx2 completely eliminated expression ofBMP2 and its downstream 
genes Dlx5 and Msx2. These results suggested that Runx2 is required in addition to 
FGF2 to work upstream ofBMP2 for the expression ofDlx5 (Choi et al.,2005). 
Alternatively, Holleville et al. used a dominant-negative construct (DlxHD-EnR) that 
interfered with chick Dlx5 transactivating activity in E6 calvaria cells transfected with a 
constitutively active type I BMP receptor (AcBMPR). Results of their studies showed 
that DlxHD-EnR prevents the induction ofRunx2 activation by BMP signals. They 
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concluded that Dlx5 or related family members such as Dlx6 are necessary for the 
initiation of Runx2 in immature chick calvaria mesenchyme triggered by BMP 
signaling (Holleville et al., 2007). These results contrast with the findings ofChoi et aL 
who found that Runx2 was involved in this cascade prior to activation ofBMP2/4. 
Differences in the results obtained by these authors may be explained by their use of 
animals from different species (Figure 9). 
The increase in spacing between parietal bone fronts in the sagittal sutures from 
Dlx5 (+1-) mice could be due to a decrease in osteoblast differentiation, changes in 
apoptosis, and/or changes in proliferation in the sutural complex. Holleville et at. 
recently showed that Dlx5 does not effect proliferation in immature calvarial cells 
(Holleville et al.,2007). In addition, Acampora et al. (1999) showed no difference in 
the apoptoic cells in a variety of tissues from the Dlx5 (-1-) compared to wt controls. 
Therefore taken together, we hypothesize that increased spacing in the sagittal suture 
seen in the Dlx5 (+1-) mice is due to a defect in osteoblast differentiation. In our study, 
we started to examine differentiation by the use of mice transgenic for Col I 2.3 GFP, 
however we have not finished analyzing the samples. 
A. Future studies 
Future studies may be useful in furthering our knowledge ofDlx5 and its role in 
cranial suture fusion. Since a phenotype was observed only in the sagittal suture of 
mutant mice, these studies may involve examining the proliferation, differentiation and 
apoptosis of cells in the sagittal suture ofDlx5 mutant and wild-type mice. 
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Additional studies that may enhance our knowledge of Dlx5 may be to knock 
out the gene postnatally. Because the homozygous mutant has such a severe phenotype, 
resulting sometimes in death at birth, we propose that the gene be knocked out 
conditionally by flox Dlx5 and giving a tamoxifen cre postnatally. This would avoid the 
problem of the lethal phenotype and still allow examination of the role of Dlx5 during 
suture fusion. 
B. Significance 
Although craniosynostosis is a rare finding, it may cause severe malformations 
and developmental disorders in those that are affected. Since the genetic etiology is 
unknown in the vast majority of human patients with sutural growth disturbances, 
evidence that a Dlx5 signaling pathway is involved in cranial suture fusion, may 
provide a new candidate gene for analysis in patients with sutural growth disturbances. 
The development of our knowledge of the genes involved in suture fusion is 
essential for progress in the medical and genetic treatment of individuals with cranial 
suture fusion disorders. 
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Figure 1. Expression of Dlx5 in the cranial sutures. Immunohistochemistry (brown) for 
Dlx5 in the Posterior frontal suture (A) and Sagittal suture (B) from 10 day-old CD-l 
wild-type mice. Sections were counterstained with Hemotoxylin (Blue). 
Figure 2. Expression ofBMP4 and Dlx5 in the cranial sutures from 21 to 45 day old 
wild-type mice. Semiquantitative RT-PCR analysis performed for BMP4~ Dlx5~ and the 
house keeping gene 18S on RNA extracted from the posterior frontal and sagittal 
sutures (A). Relative expression ofBMP4 and Dlx5 in the Sagittal/Posterior frontal 
suture from 35 day-old wild-type mice. RT-PCR products separated by electrophoresis 
were visualized after ethidium bromide staining under a UV light and photographed in a 
single field of view with a digital camera. Individual bands on digital micrographs of 
RT -PCR products were analyzed by densitometer usng Image J NIH IMAGE. Intensity 
for Dlx5 and BMP4 was calculated as a percentage of densitometry values for control 
bands of 18S. Each primer set was tested previously to assure that amplification was in 
the linear range by analyzing amplification at several different cycle numbers (B). 
Figure 3. H&E stained coronal sections of the posterior frontal suture from 10 day-old 
wild-type(A) and heterozygous Dlx5 (+1-) (B) mice. 
Figure 4. The mean distance in Ilm and standard error between osteogenic fronts of the 
posterior frontal suture in 10 day-old Dlx5 (+1+) (mean=36.5; SE=21; n=3) and Dlx5 
(+1-) (mean=78.1; SE=27.4;n=3) mice. 
Figure S. H&E stained coronal sections of the sagittal suture from 10 day-old wild-type 
(A) and heterozygous Dlx5 (+1-) (B) mice. 
Figure 6. The mean distance in Ilm and standard error between parietal bone fronts of 
the sagittal suture in 10 day-old Dlx5 (+1+) (mean=-45.9; SE=15.5; n=3) and Dlx5 (+1-) 
(mean=69; SE=27.9;n=3) mce. 
Figure 7. Transgenic Dlx5 (+1-) mice were bred with mice transgenic for the 2.3kb 
fragment of the Collagen Type I alpha 1 promoter fused to a Green Fluorescent Protein 
(2.3 GFP). GFP expression in the posterior frontal suture of 10 day-old Dlx5 (+1+)/2.3 
GFP (+1-) (A) and Dlx5 (+1-)12.3 GFP (+1-) (B) mice. 
Figure 8. Transgenic Dlx5 (+1-) mice were bred with mice transgenic for the 2.3kb 
fragment of the Collagen Type I alpha 1 promoter fused to a Green Fluorescent Protein 
(2.3 GFP). GFP expression in the sagittal suture of 10 day-old Dlx5 (+1+)/2.3 GFP (+1-) 
(A) and Dlx5 (+1-)/2.3 GFP (+1-) (B) mice. 
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